Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Ecker, G & Chiba, P 1997, 'Recent developments in overcoming tumour cell multi-drug resistance', Expert Opinion on Therapeutic Patents: authoritative analysis of patenting trends, vol. 7, pp. 589-599.

Prets, S, Jungreithmair, A, Chiba, P & Ecker, G 1996, 'Comparison of different methods for estimation of lipophilicity of propafenone-type modulators of multidrug resistance', Scientia Pharmaceutica, vol. 64, no. 3-4, pp. 627-636.

Activities

Showing entries 1 - 5 out of 207

AI in Drug Discovery and Toxicity Prediction

Gerhard Ecker
ARUA 2025
Conference, Talk or oral contribution
30.10.2025 - 30.10.2025

In silico MIE Prediction

Gerhard Ecker
RISK-HUNT3R Stakeholder Symposium
Conference, Talk or oral contribution
18.6.2025 - 18.6.2025

Prediction of Toxicity

Gerhard Ecker
CCC-Trio 2025
Conference, Talk or oral contribution
12.6.2025 - 12.6.2025

Prediction of Toxicity - let's use Fingerprints

Gerhard Ecker
OpenTox Virtual Conference 2024
Conference, Talk or oral contribution
29.11.2024 - 29.11.2024

In silica prediction of toxicity - from QSAR models to biological fingerprinting

Gerhard Ecker
AAPR 23 - patterns in one health
Conference, Talk or oral contribution
25.10.2023 - 25.10.2023